Another study noted that patients with low levels of postoperative CEA (<2.5 ng/ml) had an extremely favourable prognosis compared with those with normal or elevated postoperative CEA levels among patients with pathologic stage Ia NSCLC (Sawabata et al., 2004b). The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.